Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia
暂无分享,去创建一个
D. Drucker | M. J. Charron | C. Dai | A. Powers | P. Vuguin | Safina Ali | E. D. Dean | A. Robledo | C. Longuet | Ian McGuinness | Vincent de Chavez
[1] K. Kaestner,et al. Transcriptional regulation of α‐cell differentiation , 2011, Diabetes, obesity & metabolism.
[2] R. Kulkarni,et al. Growth factor signalling in the regulation of α‐cell fate , 2011, Diabetes, obesity & metabolism.
[3] E. Mema,et al. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency. , 2011, Endocrinology.
[4] J. Treadway,et al. Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes , 2011, BMC Genomics.
[5] Zhenguo Liu,et al. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival , 2011, Diabetologia.
[6] D. Drucker,et al. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. , 2011, The Journal of clinical investigation.
[7] J. Egan,et al. Insulin and Glucagon Regulate Pancreatic α-Cell Proliferation , 2011, PloS one.
[8] M. Sander,et al. Historical Perspective: Beginnings of the β-Cell , 2011, Diabetes.
[9] Katherine A. Winters,et al. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor. , 2010, American journal of physiology. Endocrinology and metabolism.
[10] E. Keinan,et al. Pancreatic β‐Cell Neogenesis by Direct Conversion from Mature α‐Cells , 2010, Stem cells.
[11] Min Chen,et al. Pancreas-specific Gsalpha deficiency has divergent effects on pancreatic alpha- and beta-cell proliferation. , 2010, The Journal of endocrinology.
[12] N. Morgan,et al. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes , 2010, Diabetologia.
[13] G. Warnock,et al. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. , 2010, Gastroenterology.
[14] P. Herrera,et al. Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss , 2010, Nature.
[15] Katherine A. Winters,et al. Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia , 2009, Journal of Pharmacology and Experimental Therapeutics.
[16] Tanya Hansotia,et al. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice. , 2009, Gastroenterology.
[17] Run Yu,et al. Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, &agr; Cell Hyperplasia, and Islet Cell Tumor , 2009, Pancreas.
[18] A. Means,et al. Faculty Opinions recommendation of The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. , 2009 .
[19] O. Madsen,et al. The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells , 2009, Cell.
[20] P. Gianello,et al. Native pancreatic α‐cell adaptation in streptozotocin‐induced diabetic primates: importance for pig islet xenotransplantation , 2009, Xenotransplantation.
[21] T. Asano,et al. Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver , 2008, Science.
[22] Y. Kido,et al. Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice , 2008, Molecular and Cellular Biology.
[23] Min Chen,et al. β cell-specific deficiency of the stimulatory G protein α-subunit Gsα leads to reduced β cell mass and insulin-deficient diabetes , 2007, Proceedings of the National Academy of Sciences.
[24] D. Drucker,et al. Incretin Receptors for Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Are Essential for the Sustained Metabolic Actions of Vildagliptin in Mice , 2007, Diabetes.
[25] F. Sundler,et al. Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet , 2007, Diabetologia.
[26] J. Gerich,et al. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. , 2007, Endocrine reviews.
[27] Marcela Brissova,et al. Pancreatic Islet Production of Vascular Endothelial Growth Factor-A Is Essential for Islet Vascularization, Revascularization, and Function , 2006, Diabetes.
[28] M. J. Charron,et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. , 2006, Endocrinology.
[29] O. McGuinness,et al. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. , 2006, Diabetes.
[30] O. Gavrilova,et al. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. , 2005, The Journal of clinical investigation.
[31] N. Porksen,et al. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. , 2004, The Journal of clinical investigation.
[32] Marcela Brissova,et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. , 2004, Diabetes.
[33] Jae-Hyoung Cho,et al. Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .
[34] J. Holst,et al. Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Steiner,et al. Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice. , 2002, Diabetes.
[36] K. Kaestner,et al. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. , 2001, Genes & development.
[37] C. Kahn,et al. Evidence for a circulating islet cell growth factor in insulin-resistant states , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Magnuson,et al. DNA excision in liver by an albumin‐Cre transgene occurs progressively with age , 2000, Genesis.
[39] C. Kellendonk,et al. Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.
[40] J. Holst,et al. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. , 1995, The Journal of clinical investigation.
[41] D. Drucker,et al. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors. , 1994, The American journal of physiology.
[42] F. Sundler,et al. Reinnervation of Syngeneic Mouse Pancreatic Islets Transplanted Into Renal Subcapsular Space , 1992, Diabetes.
[43] R. Unger,et al. Effects of hypoglycemia and prolonged fasting on insulin and glucagon gene expression. Studies with in situ hybridization. , 1989, The Journal of clinical investigation.
[44] W. A. Müller,et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. , 1970, The New England journal of medicine.
[45] B. Petersson,et al. EFFECTS OF LONG TERM ADMINISTRATION OF GLUCAGON ON THE PANCREATIC ISLET TISSUE OF RATS AND GUINEA-PIGS. , 1963, Acta endocrinologica.
[46] M. Sander,et al. Historical Perspective: Beginnings of the β-Cell , 2011, Diabetes.
[47] P. Herrera,et al. Conversion of adult pancreatic a-cells to b-cells after extreme b-cell loss , 2010 .
[48] E. Speel,et al. Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas. , 2009, The Journal of clinical endocrinology and metabolism.
[49] Min Chen,et al. Beta cell-specific deficiency of the stimulatory G protein alpha-subunit Gsalpha leads to reduced beta cell mass and insulin-deficient diabetes. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[50] In Kyu Lee,et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.